UnitedHealth Group’s second-quarter earnings beat Wall Street expectations as tighter cost controls and improved margins helped restore investor confidence. The stronger results prompted higher full-year guidance and suggested the healthcare giant’s turnaround strategy is beginning to gain traction despite ongoing industry challenges.
NYU Langone Health’s proposed academic medical center in Melville represents one of the largest healthcare investments on Long Island in decades. Combining patient care, medical education and research, the development could reshape healthcare access, workforce development and regional economic growth.
In oncology biotech, legal teams play a central role in advancing scientific innovation within complex regulatory and policy environments. At Exelixis, General Counsel Brenda Hefti, J.D., Ph.D., exemplifies that role by aligning legal strategy with scientific innovation and business objectives. She helps drive the delivery of therapies to patients while guiding the company through litigation, intellectual property strategy, regulatory challenges, and evolving government policy — positioning Exelixis at the critical intersection of law and science.
In everyday clinical practice, symptoms usually appear long before a diagnosis is made. One patient presents with resistant hypertension. Another reports persistent, unrelenting fatigue. A third struggles with attention and concentration at school or work. These cases move routinely through primary care, cardiology, endocrinology, psychiatry, and paediatrics. Yet sleep is rarely placed at the centre of the diagnostic process, even when the pattern of symptoms points strongly in that direction.
As a result, care often focuses on managing downstream effects while the underlying cause goes unrecognised and untested.








